Thus, it appears that the concentration and activity of LCAT increases with obesity and obesity-associated low-grade inflammation, suggesting a compensatory mechanism, but appears to decrease when it comes to severe comorbidities and pathological conditions [35,47,48,49]. This evidence concerns the gene LCAT and obesity disorder.